DelveInsight’s Atrial Flutter Market report provides an in-depth understanding of Atrial Flutter, historical and forecasted epidemiology, as well as Atrial Flutter market trends in the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. The report also examines current Atrial Flutter treatment practices/algorithms, market drivers, market barriers, and unmet medical needs in order to identify and evaluate the market’s underlying potential.
Some Key Highlights from the Atrial Flutter Market Report
Atrial flutter is the second most frequent cardiac arrhythmia after Atrial Fibrillation, according to Ziccardi et al. (2020). Males are more likely than females to experience Atrial Flutter. A higher incidence of Atrial Fibrillation and Atrial Flutter is linked to getting older.
According to the Global Health Data Exchange, around 8 out of 10 persons suffering or diagnosed with Atrial Fibrillation or Atrial Flutter are found to be 65 years old or older in age.
AcQBlate Force Sensing Ablation System (Acutus Medical) and Gencaro (ARCA Biopharma) are the emerging therapies in the Atrial Flutter market.
Acutus Medical, ARCA Biopharma, Abbott, Adagio Medical, among others are the major companies involved in the Atrial Flutter market.
For more information request sample @ Atrial Flutter Market Insights
Atrial Flutter market report include current treatment methods, developing medications, Atrial Flutter market share of individual therapies, current and anticipated Atrial Flutter market size from 2018 to 2030 segmented by seven major markets.
Atrial Flutter: Disease Overview
Atrial Flutter is an arrhythmia in which the heart beats irregularly. Atrial Flutter is referred to as supraventricular (above the ventricles) tachycardia because it originates in the atria. The upper chambers of the heart (atria) beat too fast in Atrial Flutter. The heart beats faster, but normally in a steady rhythm as a result of this. It has a fast heart rate of 250-400 beats per minute.
Atrial Flutter Epidemiology Segmentation
Atrial Flutter Total Incident Cases
Atrial Flutter Total Incident Cases Segmented by Age
Atrial Flutter Total Incident Cases Segmented by Gender
Atrial Flutter Total Treated Cases
Atrial Flutter Treatment Landscape
The most important goal of treatment is to get the patient’s heart rate back to normal. The treatment for Atrial Flutter is determined on the cause, the patient’s symptoms, and the risk of stroke. The current treatment options for Atrial Flutter are:
Cardioversion
Ablation
Anti-arrhythmic
Calcium channel blockers
Beta-blockers
Atrial Flutter Market
The growing senior population and increased incidence of Atrial Flutter in the 7MM have resulted in an increase in Atrial Flutter market size.
Key pharmaceutical companies such as Acutus Medical, ARCA Biopharma, Abbott, Adagio Medical, and others are expected to launch new therapies in the Atrial Flutter market.
Learn more about atrial flutter @ Atrial Flutter Treatment Landscape and Market Outlook
Atrial Flutter Pipeline Therapies
AcQBlate Force Sensing Ablation System: Acutus Medical
Gencaro: ARCA Biopharma
Atrial Flutter Major Companies
Acutus Medical
ARCA Biopharma
Abbott
Adagio Medical
Atrial Flutter Market Drivers
Upsurge in the number of incident cases of Atrial Flutter
Increase in aging population
Atrial Flutter Market Barriers
Limited knowledge of Atrial Flutter
Currently more focus on Atrial Fibrillation rather than Atrial Flutter
Scope for the Report
Coverage: 7MM (the US, EU5 (the UK, Germany, Italy, Spain and France) and Japan)
Study Period: 2018-30
Atrial Flutter Key Companies: Acutus Medical, ARCA Biopharma, Abbott, Adagio Medical, among others.
Atrial Flutter Key Pipeline Therapies: AcQBlate Force Sensing Ablation System (Acutus Medical) and Gencaro (ARCA Biopharma), and others.
Table of Contents
1.
Report Introduction
2.
Executive Summary of Atrial Flutter
3.
SWOT Analysis of Atrial Flutter
4.
Atrial Flutter: Patient Share (%) Overview at a Glance
5.
Atrial Flutter: Market Overview (%) at a Glance
6.
Atrial Flutter Disease Background and Overview
7.
Atrial Flutter Epidemiology and Patient Population
8.
Country-Specific Patient Population of Atrial Flutter
9.
Atrial Flutter Current Treatment and Medical Practices
10.
Atrial Flutter Patient Journey
11.
Atrial Flutter Unmet Needs
12.
Atrial Flutter Key Endpoint of Clinical Trials
13.
Atrial Flutter Marketed Products
14.
Atrial Flutter Emerging Therapies
15.
Atrial Flutter: Market Size of 7MM
16.
Atrial Flutter Country-Wise Market Analysis (2018–2030)
17.
Market Access and Reimbursement of Atrial Flutter
18.
Atrial Flutter Market drivers
19.
Atrial Flutter Market barriers
20.
Appendix
21.
DelveInsight Capabilities
22.
Disclaimer
23.
About DelveInsight
For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare and Biotech Blog Posts
Related Reports
Atrial Fibrillation Market
Get comprehensive historical and forecast analysis of Atrial Fibrillation Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Abbott Laboratories, Johnson & Johnson, MicroPort Scientific Corporation, Boston Scientific Corporation, St. Jude Medical, Inc., Medtronic plc, Biotronik SE & Co. KG, Koninklijke Philips N.V., Siemens AG, and AtriCure Inc., among others.
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Sandeep JoshiEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: www.delveinsight.com/